ETF Holdings Breakdown of RVMD

Stock NameRevolution Medicines Inc
TickerRVMD(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS76155X1000
LEI549300JU3X0LBCQ65892

News associated with RVMD

Guggenheim Reiterates Buy Rating for Revolution Medicines (NASDAQ:RVMD)
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a research note issued to investors on Wednesday,Benzinga reports. They presently have a $80.00 price target on the stock. Guggenheim’s target price points to a potential upside of 113.45% from the stock’s current price. Several other […] - 2025-06-27 05:54:43
Revolution Medicines (NASDAQ:RVMD) Earns “Buy” Rating from Needham & Company LLC
Revolution Medicines (NASDAQ:RVMD – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $57.00 target price on the stock. Needham & Company LLC’s price target would indicate a potential upside of 48.40% from the company’s […] - 2025-06-26 06:13:04
Harbor Capital Advisors Inc. Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)
Harbor Capital Advisors Inc. acquired a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 35,417 shares of the company’s stock, valued at approximately $1,252,000. A number of other hedge funds also recently made […] - 2025-06-13 08:20:59
Analysts Set Revolution Medicines, Inc. (NASDAQ:RVMD) Price Target at $67.08
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus rating of “Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Twelve research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have updated their coverage on […] - 2025-06-04 05:36:53
Financial Contrast: Revolution Medicines (NASDAQ:RVMD) & Fate Therapeutics (NASDAQ:FATE)
Fate Therapeutics (NASDAQ:FATE – Get Free Report) and Revolution Medicines (NASDAQ:RVMD – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation. Volatility & Risk Fate Therapeutics has a beta […] - 2025-05-28 05:34:49
Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Bought by Envestnet Asset Management Inc.
Envestnet Asset Management Inc. raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 21.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 11,425 shares of the company’s stock after buying an additional 2,041 shares during the period. Envestnet Asset Management Inc.’s holdings in Revolution Medicines were worth $500,000 as […] - 2025-05-05 07:36:57
CANADA LIFE ASSURANCE Co Acquires 545 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)
CANADA LIFE ASSURANCE Co lifted its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 5.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,398 shares of the company’s stock after purchasing an additional 545 shares during the […] - 2025-04-30 08:48:55
Wedbush Reaffirms Outperform Rating for Revolution Medicines (NASDAQ:RVMD)
Wedbush reaffirmed their outperform rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research report report published on Monday,Benzinga reports. They currently have a $67.00 target price on the stock. Other equities analysts have also issued research reports about the stock. UBS Group lifted their price target on shares of Revolution Medicines […] - 2025-04-29 07:42:49
Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Acquired by Sterling Capital Management LLC
Sterling Capital Management LLC increased its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 588.7% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,956 shares of the company’s stock after buying an additional 1,672 shares during the period. Sterling Capital Management LLC’s holdings in Revolution Medicines were worth $86,000 […] - 2025-04-23 08:36:53
Raymond James Financial Inc. Takes Position in Revolution Medicines, Inc. (NASDAQ:RVMD)
Raymond James Financial Inc. acquired a new position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 321,611 shares of the company’s stock, valued at approximately $14,067,000. Raymond James Financial Inc. owned approximately 0.19% of Revolution Medicines […] - 2025-04-22 08:10:59
Needham & Company LLC Reiterates Buy Rating for Revolution Medicines (NASDAQ:RVMD)
Needham & Company LLC reiterated their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a research note released on Tuesday,Benzinga reports. The brokerage currently has a $59.00 price objective on the stock. Several other equities analysts have also weighed in on RVMD. Wedbush reissued an “outperform” rating and set a $67.00 […] - 2025-04-11 08:16:58
Revolution Medicines (NASDAQ:RVMD) Hits New 1-Year Low – Time to Sell?
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) hit a new 52-week low during mid-day trading on Saturday . The stock traded as low as $30.94 and last traded at $31.32, with a volume of 2376753 shares. The stock had previously closed at $32.87. Analysts Set New Price Targets A number of brokerages recently issued […] - 2025-04-07 05:40:44
Revolution Medicines (NASDAQ:RVMD) Price Target Lowered to $64.00 at Stifel Nicolaus
Revolution Medicines (NASDAQ:RVMD – Free Report) had its price objective cut by Stifel Nicolaus from $78.00 to $64.00 in a research report released on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Several other research firms have also recently weighed in on RVMD. Guggenheim upped their price objective on Revolution Medicines from […] - 2025-04-02 07:18:58
Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Purchased by Corebridge Financial Inc.
Corebridge Financial Inc. increased its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 2.1% in the 4th quarter, HoldingsChannel reports. The firm owned 83,213 shares of the company’s stock after buying an additional 1,739 shares during the quarter. Corebridge Financial Inc.’s holdings in Revolution Medicines were worth $3,640,000 at the end […] - 2025-03-31 08:22:47
Xponance Inc. Has $530,000 Stock Position in Revolution Medicines, Inc. (NASDAQ:RVMD)
Xponance Inc. raised its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 21.4% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 12,127 shares of the company’s stock after acquiring an additional 2,140 shares during the quarter. Xponance Inc.’s holdings in Revolution Medicines were worth $530,000 at the end of the […] - 2025-03-26 08:24:54
Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $66.31 Average Price Target from Analysts
Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been assigned a consensus recommendation of “Buy” from the thirteen analysts that are covering the company, MarketBeat Ratings reports. Twelve research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price […] - 2025-03-21 05:20:52
Raymond James Financial Inc. Invests $14.07 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)
Raymond James Financial Inc. bought a new position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 321,611 shares of the company’s stock, valued at approximately $14,067,000. Raymond James Financial […] - 2025-03-19 08:00:47
US Bancorp DE Sells 1,264 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)
US Bancorp DE decreased its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 51.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 1,191 shares of the company’s stock after selling 1,264 shares during the period. US Bancorp DE’s holdings in Revolution Medicines were worth $52,000 at the end of the most recent […] - 2025-03-19 07:10:50
Revolution Medicines, Inc. (NASDAQ:RVMD) Shares Purchased by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. boosted its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 521.8% in the fourth quarter, HoldingsChannel.com reports. The firm owned 3,787 shares of the company’s stock after buying an additional 3,178 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Revolution Medicines were worth $165,000 as of its […] - 2025-03-17 08:06:53
Arizona State Retirement System Has $1.48 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD)
Arizona State Retirement System boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 2.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 33,905 shares of the company’s stock after buying an additional 650 shares during the quarter. Arizona State Retirement […] - 2025-03-13 07:42:51
Revolution Medicines, Inc. (NASDAQ:RVMD) Position Lowered by Victory Capital Management Inc.
Victory Capital Management Inc. reduced its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 1.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 430,462 shares of the company’s stock after selling 7,288 shares during the quarter. Victory […] - 2025-03-12 07:55:07
Charles Schwab Investment Management Inc. Purchases 167,997 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)
Charles Schwab Investment Management Inc. boosted its position in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 9.5% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,931,114 shares of the company’s stock after buying an additional 167,997 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Revolution Medicines were worth $84,467,000 […] - 2025-03-11 08:01:13
Amalgamated Bank Buys 435 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)
Amalgamated Bank boosted its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 8.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,707 shares of the company’s stock after acquiring an additional 435 shares during the period. […] - 2025-03-05 09:55:10
CIBC Asset Management Inc Has $220,000 Stock Position in Revolution Medicines, Inc. (NASDAQ:RVMD)
CIBC Asset Management Inc grew its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) by 5.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,037 shares of the company’s stock after buying an additional 270 shares during the […] - 2025-02-26 08:54:51

RVMD institutional holdings

The following institutional investment holdings of RVMD have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-26 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 92,376USD 3,462,252 -2.5%
2025-06-26 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 21,142USD 792,402
2025-06-19 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 206,658USD 8,251,854
2025-06-26 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 92,951USD 3,483,803
2025-06-26 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 92,951USD 3,483,803
2025-06-26 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 537USD 20,127
Total =506,615 USD 19,494,241
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.